Document text
Principal Investigator: Yasmine Belkaid
Organization: NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Fiscal Year: 2023
Award: $5,049,028
Funding agency: National Institute of Allergy and Infectious Diseases
In response to the SARS-CoV-2 pandemic we have made the advanced technologies platforms and basic and complex informatics at CHI available for characterization of COVID-19 patient samples, as a priority ahead of our ongoing collaborative studies. The CHI program contributed to two publications and a further four ongoing studies related to COVID-19 during this fiscal year. In collaboration with Dr. John Tsang, CHI performed high-parameter cytometry including staining for antigen-specific cells to investigate the consequences of mild Covid infection in a study which was reported in Nature. In collaboration with Dr. Kalpana Manthiparam, CHI collaboratively worked to generate CITE-seq and analysis cytometry to characterize infection in children and lymph nodes in study which was reported in Nature Immunology. This project has continued as a collaboration from the November 2022 call, to study vaccine responses in children and lymph nodes with CHI taking on an increasing role in CITE-seq data generation (appendix A, study 306). Three further Covid studies have been undertaken under technology development application and partnerships. With Dr. Pamela Guererrio CHI is completing bulk RNA-seq, serum proteomics, and high-parameter color flow cytometry for over 200 samples from a cohort to address adverse reactions to Covid mRNA vaccination (appendix B, study 208). With Dr. Iain Fraser CHI has completed CITE-seq for a study treating Covid infection with Fostamatinib (appendix B, study 314). With Dr Ligia Pinto CHI has completed SomaLogic of 400 samples from the NCI/NIAID SeroNet program characterizing responses after mRNA vaccination (appendix B, study 316). Additional Covid studies that are under discussion for new technology partnerships include studies with Mihalis Lionakis, Pamela Guererrio, and Iain Fraser.
Terms: <0-11 years old><2019 novel corona virus><2019 novel coronavirus><2019-nCoV><Address><Adverse reactions><Antigens><Assay><Bioassay><Biologic Assays><Biological><Biological Assay><Blood Serum><CITE sequencing><CITE-seq><CITEseq><COVID crisis><COVID epidemic><COVID infected patient><COVID pandemic><COVID patient><COVID positive patient><COVID-19><COVID-19 crisis><COVID-19 epidemic><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 infected patient><COVID-19 pandemic><COVID-19 patient><COVID-19 positive patient><COVID-19 public health crisis><COVID-19 virus><COVID19><COVID19 crisis><COVID19 epidemic><COVID19 global health crisis><COVID19 global pandemic><COVID19 health crisis><COVID19 pandemic><COVID19 patient><COVID19 positive patient><COVID19 public health crisis><COVID19 virus><CV-19><CV19><Cell Body><Cells><Cellular Indexing of Transcriptomes and Epitopes by Sequencing><Child><Child Youth><Children (0-21)><Clinical Research><Clinical Study><CoV-2><CoV2><Collaborations><Color><Communities><Complex><Computer Analysis><Computer Models><Computerized Models><Coupled><Cytometry><Data><Development><Fee-for-Service Plans><Fees for Service><Flow Cytofluorometries><Flow Cytofluorometry><Flow Cytometry><Flow Microfluorimetry><Flow Microfluorometry><Generations><Goals><Human><Immune><Immune Monitoring><Immune mediated therapy><Immunes><Immunity><Immunologic Monitoring><Immunological Monitoring><Immunologically Directed Therapy><Immunology><Immunomonitoring><Immunotherapy><Individual><Infection><Informatics><Intervention><Intervention Strategies><Investigators><Laboratories><Leadership><Lymph Node Reticuloendothelial System><Lymph node proper><Lymphatic nodes><Microbiomics><Mission><Modeling><Modern Man><Monitor><NIAID><NIH><National Institute of Allergy and Infectious Disease><National Institutes of Health><Nature><Outcome><Proteomics><Publications><RNA Seq><RNA immunization><RNA sequencing><RNA vaccination><RNAseq><Reporting><Research><Research Personnel><Research Resources><Researchers><Resources><Review Committee><Role><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV-2 epidemic><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 infected patient><SARS-CoV-2 pandemic><SARS-CoV-2 patient><SARS-CoV-2 positive patient><SARS-CoV2><SARS-CoV2 epidemic><SARS-CoV2 pandemic><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Sampling><Scientific Publication><Serum><Services><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 pandemic><Severe acute respiratory syndrome related corona virus 2><Staining method><Stains><System><Technology><Translational Research><Translational Science><United States National Institutes of Health><Vaccination><Work><Wuhan coronavirus><biologic><cellular indexing of transcriptomes and epitopes by single cell sequencing><clinical applicability><clinical application><cohort><collaborative approach><computational analyses><computational analysis><computational modeling><computational models><computer analyses><computer based models><computerized modeling><corona virus disease 2019><corona virus disease 2019 epidemic><corona virus disease 2019 pandemic><coronavirus disease 2019><coronavirus disease 2019 crisis><coronavirus disease 2019 epidemic><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 infected patient><coronavirus disease 2019 pandemic><coronavirus disease 2019 patient><coronavirus disease 2019 positive patient><coronavirus disease 2019 public health crisis><coronavirus disease 2019 virus><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease infected patient><coronavirus disease pandemic><coronavirus disease patient><coronavirus disease positive patient><coronavirus disease-19><coronavirus disease-19 global pandemic><coronavirus disease-19 pandemic><coronavirus disease-19 patient><coronavirus disease-19 virus><coronavirus infectious disease-19><coronavirus patient><data mining><data modeling><datamining><design><designing><developmental><flow cytophotometry><hCoV19><high dimensionality><immune therapeutic approach><immune therapeutic interventions><immune therapeutic regimens><immune therapeutic strategy><immune therapy><immune-based therapies><immune-based treatments><immuno therapy><immunogen><insight><interest><interventional strategy><kids><lymph gland><lymph nodes><lymphnodes><mRNA immunization><mRNA vaccination><microbial consortia><microbial flora><microbiome><microbiome research><microbiome science><microbiome studies><microbiota><microflora><model of data><model the data><modeling of the data><multispecies consortia><nCoV2><new technology><novel technologies><patient infected with COVID><patient infected with COVID-19><patient infected with SARS-CoV-2><patient infected with coronavirus disease><patient infected with coronavirus disease 2019><patient infected with severe acute respiratory syndrome coronavirus 2><patient with COVID><patient with COVID-19><patient with COVID19><patient with SARS-CoV-2><patient with coronavirus disease><patient with coronavirus disease 2019><patient with severe acute respiratory distress syndrome coronavirus 2><programs><recruit><response><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><severe acute respiratory syndrome coronavirus 2 infected patient><severe acute respiratory syndrome coronavirus 2 patient><severe acute respiratory syndrome coronavirus 2 positive patient><social role><tech development><technology development><technology platform><technology system><transcriptome sequencing><transcriptomic sequencing><transcriptomics><translation research><translational investigation><vaccination study><vaccination trial><vaccine response><vaccine responsiveness><vaccine study><vaccine trial><vaccine-induced response><youngster>